Date updated:11-01-2006
Here is a portfolio of stem cell stocks that could be interesting depending on which party wins in the mid term elections.

-
GERN
Geron Corporation - $5.58
- -2.62%
- $5.65
Geron Corporation operates as a biopharmaceutical company and intends to use human embryonic stem cell technology to enable the development of transplantation therapies by providing starting material for the manufacture of cells and tissues.

-
ASTM
Aastrom Bioscienc - $0.31
- 0.00%
- $0.3088
Aastrom Biosciences, Inc., a development stage company, focuses on the development of autologous cell products for use in regenerative medicine.

-
STEM
Stemcells - $1.09
- 0.00%
- $1.12
StemCells, Inc., a biopharmaceutical company, engages in the discovery and development of adult stem cell therapeutics to treat damage to; or degeneration of major organ systems, such as the central nervous system, liver, and pancreas.

-
VIAC
Viac - $0.00
- N/A
- $N/A
ViaCell, Inc., a biotechnology company, engages in the research, development, and commercialization of cellular therapies in the United States and Singapore. It develops a pipeline of proprietary umbilical cord blood-derived and adult-derived stem cell product candidates as treatments for cancer, cardiac disease, and diabetes.

-
ACTC.OB
Advanced Cell Tec - $0.108
- +8.00%
- $0.109
Advanced Cell Technology, Inc., a biotechnology company, engages in the development and commercialization of human stem cell technology in the fields of regenerative medicine and stem cell therapy in the United States.

-
IVGN
N/a - $24.76
- 0.00
- $24.76
Invitrogen Corporation provides products and services that support academic and government research institutions, as well as pharmaceutical and biotechnology companies. The company operates in two segments, BioDiscovery and BioProduction. BioDiscovery segment offers functional genomics, cell biology, and drug discovery product lines. Functional genomics product line includes the research tools used in reagent and kit form for gene acquisition, gene cloning, gene expression, and gene analysis techniques.

-
ALXN
Alexion Pharmaceu - $43.70
- -1.04%
- $43.82
Alexion Pharmaceuticals, Inc., a biotechnology company, together with its subsidiaries, engages in the discovery and development of biologic therapeutic products for the treatment of severe diseases in the United States.

-
LIFC
Lifecell Corporat - $0.00
- 0.00%
- $N/A
LifeCell Corporation engages in the development and marketing of human-derived tissue-based products for use in reconstructive, orthopedic, and urogynecologic surgical procedures to repair soft tissue defects.
- Top Professional Portfolios
- 1. Fidelity Contrafund - ...
- 2. Navellier & Associ...
- 3. Calamos Advisors
- 4. Argus Management
- 5. Bernard L. Madoff Inve...
- show all
- Top Do-It-Yourself Portfolios
- » Joseph Russell Portfolio 1
- » Albo's First Portfolio
- » Darrell Werth Portfolio 1
- » Echo5Joker's Portfolio
- » jgroov Portfolio 1
- show all
- Most Viewed Portfolios
- » Warren Buffett
- » George Soros
- » T. Boone Pickens - BP Cap...
- » Carl Icahn
- » Renaissance Technologies
- show all
Not a Stockpickr member? Join the community today -- for free.Regardless of why a stock is in the news, it never hurts to hear what a professional investor has to say about...
By Roberto Pedone Posted on Nov. 20, 2009 According to Jim Cramer, options expiration is driving the current market selloff. He pointed out that the only stocks that we...
By Roberto Pedone Posted on Nov. 19, 2009 According to CNBC’s “Fast Money” traders, the stock market is showing no signs of stopping its current bull run. Joe Ter...
By Jonas Elmerraji Posted on Nov. 18, 2009 There are plenty of reasons for stocks to have the attention of short-sellers. Waning financials, a deteriorating business mo...
A. If you are standing in line on Black
Friday watch out for pickpockets
disguised as shoppers.Also CNN Money has
a bias against people running their own
investment portfolio.They think you
should be only in mutual or index
funds.If you need a good laugh pick up a
copy of Money Magazine for a lesson in
Economic Propaganda.
A. The only one I own : SLX,
too hard pick a winner out all of them
Here is a list of some of the biggest stocks that hit 52-week lows on Nov. 20, 2009. more
Here are some of the largest % gainers from Nov. 20, 2009. more
Unusually active options can often indicate that a major event in a stock is about to take place, or that unsophisticated investors (using options in lieu of leverage) are ... more













Comments not available